NVAX Jul 2024 16.500 put

OPR - OPR Delayed Price. Currency in USD

Add to watchlist

3.9500

+0.3000

(+8.22%)

As of 02:19PM EDT. Market open.

Loading interactive chart...

Zacks
Novavax (NVAX) Falls More Steeply Than Broader Market: What Investors Need to Know
Novavax (NVAX) reachead $12.66 at the closing of the latest trading day, reflecting a -1.33% change compared to its last close.
Investor's Business Daily
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Novavax stock has pulled back after hitting a nearly two-year high earlier this month. Is NVAX stock a buy right now?
GuruFocus.com
Insider Sale: Director James Young Sells Shares of Novavax Inc (NVAX)
The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 61,760 shares of Novavax Inc. Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of innovative vaccines to prevent serious infectious diseases.